Gilder Gagnon Howe & Co’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-19,648
Closed -$948K 280
2016
Q3
$948K Buy
19,648
+715
+4% +$36.2K 0.02% 190
2016
Q2
$1.05M Sell
18,933
-198
-1% -$10.9K 0.02% 185
2016
Q1
$1.02M Sell
19,131
-8
-0% -$394 0.02% 166
2015
Q4
$985K Sell
19,139
-202
-1% -$10K 0.02% 177
2015
Q3
$873K Sell
19,341
-5,030
-21% -$238K 0.01% 192
2015
Q2
$1.13M Buy
24,371
+2,170
+10% +$95K 0.01% 212
2015
Q1
$952K Sell
22,201
-24
-0.1% -$915 0.01% 205
2014
Q4
$772K Sell
22,225
-850
-4% -$28.2K 0.01% 209
2014
Q3
$747K Sell
23,075
-7,823
-25% -$262K 0.01% 219
2014
Q2
$1.05M Buy
30,898
+507
+2% +$16.2K 0.01% 220
2014
Q1
$828K Buy
30,391
+567
+2% +$16.8K 0.01% 217
2013
Q4
$1.07M Sell
29,824
-24
-0.1% -$797 0.02% 206
2013
Q3
$899K Buy
29,848
+2,976
+11% +$97.3K 0.01% 214
2013
Q2
$783K Buy
+26,872
New +$758K 0.01% 222

Other funds holding PBH

Gilder Gagnon Howe & Co's PBH Position: Q4 2016 in Review

Gilder Gagnon Howe & Co sold out of Prestige Consumer Healthcare (PBH) in Q4 2016, closing a stake of 19,648 shares — an estimated $948K sold.

Gilder Gagnon Howe & Co first reported a position in PBH in Q2 2013 and held it in 14 quarters. The position peaked at $1.13M in Q2 2015. 238 funds tracked by Wall St. Rank hold PBH as of Q4 2016.

  • Gilder Gagnon Howe & Co reported no remaining Prestige Consumer Healthcare position as of Q4 2016 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 19,648 Prestige Consumer Healthcare shares in Q4 2016, an estimated $948K.
  • Gilder Gagnon Howe & Co first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 14 quarters.
  • Gilder Gagnon Howe & Co's Prestige Consumer Healthcare position peaked at $1.13M in Q2 2015.
  • 238 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2016.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2016, filed 1 Feb 2017.